Assessment of adherence to the CONSORT statement for quality of reports on randomized controlled trial abstracts from four high-impact general medical journals

被引:99
作者
Ghimire, Saurav [1 ]
Kyung, Eunjung [1 ]
Kang, Wonku [2 ]
Kim, Eunyoung [1 ]
机构
[1] Chungnam Natl Univ, Dept Clin Pharm, Coll Pharm, Taejon 305764, South Korea
[2] Yeungnam Univ, Coll Pharm, Kyungbuk 712749, South Korea
关键词
Randomized controlled trials; CONSORT for abstracts; Quality of reports; General medical journals; STRUCTURED ABSTRACTS; RECOMMENDATIONS; EXPLANATION; ADOPTION; NEEDS;
D O I
10.1186/1745-6215-13-77
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The extended Consolidated Standards of Reporting Trials (CONSORT) Statement for Abstracts was developed to improve the quality of reports of randomized controlled trials (RCTs) because readers often base their assessment of a trial solely on the abstract. To date, few data exist regarding whether it has achieved this goal. We evaluated the extent of adherence to the CONSORT for Abstract statement for quality of reports on RCT abstracts by four high-impact general medical journals. Methods: A descriptive analysis of published RCT abstracts in The New England Journal of Medicine (NEJM), The Lancet, The Journal of American Medical Association (JAMA), and the British Medical Journal (BMJ) in the year 2010 was conducted by two reviewers, independently extracting data from a MEDLINE/PubMed search. Results: We identified 271 potential RCT abstracts meeting our inclusion criteria. More than half of the abstracts identified the study as randomized in the title (58.7%; 159/271), reported the specific objective/hypothesis (72.7%; 197/271), described participant eligibility criteria with settings for data collection (60.9%; 165/271), detailed the interventions for both groups (90.8%; 246/271), and clearly defined the primary outcome (94.8%; 257/271). However, the methodological quality domains were inadequately reported: allocation concealment (11.8%; 32/271) and details of blinding (21.0%; 57/271). Reporting the primary outcome results for each group was done in 84.1% (228/271). Almost all of the abstracts reported trial registration (99.3%; 269/271), whereas reports of funding and of harm or side effects from the interventions were found in only 47.6% (129/271) and 42.8% (116/271) of the abstracts, respectively. Conclusions: These findings show inconsistencies and non-adherence to the CONSORT for abstract guidelines, especially in the methodological quality domains. Improvements in the quality of RCT reports can be expected by adhering to existing standards and guidelines as expressed by the CONSORT group.
引用
收藏
页数:7
相关论文
共 32 条
[1]  
[Anonymous], 2010, J PHARMACOL PHARMACO, V1, P42
[2]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[3]   The quality of reporting of trial abstracts is suboptimal: Survey of major general medical journals [J].
Berwanger, Otavio ;
Ribeiro, Rodrigo A. ;
Finkelsztejn, Alessandro ;
Watanabe, Marcelo ;
Suzumura, Erica A. ;
Duncan, Bruce B. ;
Devereaux, P. J. ;
Cook, Deborah .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2009, 62 (04) :387-392
[4]   The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Moher, D ;
Rennie, D ;
de Vet, HCW ;
Lijmer, JG .
CLINICAL CHEMISTRY, 2003, 49 (01) :7-18
[5]   CONSORT statement: extension to cluster randomised trials [J].
Campbell, MK ;
Elbourne, DR ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7441) :702-708
[6]   Randomized, controlled trials, observational studies, and the hierarchy of research designs. [J].
Concato, J ;
Shah, N ;
Horwitz, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1887-1892
[7]   Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors [J].
De Angelis, C ;
Drazen, JM ;
Frizelle, FA ;
Haug, C ;
Hoey, J ;
Horton, R ;
Kotzin, S ;
Laine, C ;
Marusic, A ;
Overbeke, AJPM ;
Schroeder, TV ;
Sox, HC ;
Van der Weyden, MB .
LANCET, 2005, 365 (9474) :1827-1829
[8]   Quality of abstracts in 3 clinical dermatology journals [J].
Dupuy, A ;
Khosrotehrani, K ;
Lebbé, C ;
Rybojad, M ;
Morel, P .
ARCHIVES OF DERMATOLOGY, 2003, 139 (05) :589-593
[9]   Are leading medical journals following their own policies on CONSORT reporting? [J].
Folkes, Amy ;
Urquhart, Robin ;
Grunfeld, Eva .
CONTEMPORARY CLINICAL TRIALS, 2008, 29 (06) :843-846
[10]   WHO facilitates international collaboration in setting standards for clinical trial registration [J].
Gülmezoglu, AM ;
Pang, T ;
Horton, R ;
Dickersin, K .
LANCET, 2005, 365 (9474) :1829-1831